Clinical Trials for Drug: INC424

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-17-31 An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis Open